Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm
Badi Rawashdeh a , Richard Bell b , Abdul Hakeem b , Raj Prasad a , ∗
a Division of Transplant Surgery, Department of General Surgery, Medical College of Wisconsin, Milwaukee, WI, 53226, USA
b Leeds Teaching Hospital, Leeds, UK
Abstract：Colorectal cancer is a leading cause of cancer-related mortality, with nearly half of the affected patients developing liver metastases. For three decades, liver resection (LR) has been the primary curative strategy, yet its applicability is limited to about 20% of cases. Liver transplantation (LT) for unresectable metastases was attempted unsuccessfully in the 1990s, with high rates of perioperative death and recurrence. There is now more interest in this strategy due to improvements in systemic therapies and surgical techniques. A significant study conducted by the Oslo group showed that patients receiving liver transplants had a 60% chance of survival after five years. Significantly better results have been achieved by using advanced imaging for risk stratification and further refining selection criteria, especially in the Norvegian SECA trials. This review carefully charts the development and history of LT as a treatment option for colorectal cancer liver metastases. The revolutionary path from the early days of exploratory surgery to the current situation of cautious optimism is traced, highlighting the critical clinical developments and improved patient selection standards that have made LT a potentially curative treatment for such challenging very well selected cases.
. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(2): 154-159.
Rawashdeh B, Bell R, Hakeem A, Prasad R. Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm. Hepatobiliary Pancreat Dis Int, 2024, 23(2): 154-159.
2024, Vol. 23 
